Medsurg was Solventum’s largest segment in fiscal 2025, bringing in $2.93B of $6.14B (48%).
| Segment | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Medsurg | $4.59B | $4.63B | $4.64B | $2.93B |
| Dental Solutions | $1.33B | — | — | $1.35B |
| Health Information Systems | $1.23B | — | — | $1.36B |
| Purification & Filtration | $991.00M | $689.00M | $709.00M | $497.00M |
| Total | $8.13B | $5.32B | $5.35B | $6.14B |
Solventum brought in $6.14B from its four segments in fiscal 2025, the year ended December 31, 2025. That is less than the $8.40B it reports by product and service, so these segments do not cover all of its revenue. Medsurg was the largest at $2.93B (47.8%), ahead of Health Information Systems at $1.36B (22.1%) and Dental Solutions at $1.35B (22.0%). The remaining segment, Purification & Filtration, brought in $497.00M.
Compared with fiscal 2024, Purification & Filtration fell 29.9% to $497.00M and Medsurg fell 36.7% to $2.93B. Some of that change comes from Solventum regrouping its segments.
United States was Solventum’s largest region in fiscal 2025, bringing in $4.67B of $8.33B (56%).
| Geography | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| United States | $4.45B | $4.47B | $4.56B | $4.67B |
| International | $3.68B | $3.73B | $3.70B | $3.66B |
| Total | $8.13B | $8.20B | $8.25B | $8.33B |
Solventum brought in $8.33B from its two regions in fiscal 2025, the year ended December 31, 2025. That was up 0.9% from $8.25B in fiscal 2024. United States was the largest at $4.67B (56.1%), ahead of International at $3.66B (43.9%).
Compared with fiscal 2024, United States grew 2.4% to $4.67B, while International fell 1.0% to $3.66B. From fiscal 2022 to 2025, combined revenue from these regions grew from $8.13B to $8.33B, a compound annual growth rate of 0.8%. United States' share of the total rose from 54.7% to 56.1%.
Cost Of Product was Solventum’s largest product and service line in fiscal 2025, bringing in $6.43B of $8.40B (76%).
| Product and Service | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|
| Cost Of Product | $6.30B | $6.30B | $6.40B | $6.43B |
| Cost Of Software & Rentals | $1.83B | $1.90B | $1.91B | $1.98B |
| Total | $8.13B | $8.20B | $8.30B | $8.40B |
Solventum brought in $8.40B from its two product and service lines in fiscal 2025, the year ended December 31, 2025. That was up 1.2% from $8.30B in fiscal 2024. Cost Of Product was the largest at $6.43B (76.5%), ahead of Cost Of Software & Rentals at $1.98B (23.5%).
Compared with fiscal 2024, Cost Of Software & Rentals grew 3.7% to $1.98B and Cost Of Product grew 0.5% to $6.43B. From fiscal 2022 to 2025, combined revenue from these lines grew from $8.13B to $8.40B, a compound annual growth rate of 1.1%. Cost Of Product's share of the total fell from 77.5% to 76.5%.
Solventum (SOLV) reports its revenue by segment, by geography and by product and service. In fiscal 2025, Medsurg was its largest segment, bringing in $2.93B (47.8% of the total), followed by Health Information Systems at $1.36B (22.1%).
Medsurg was Solventum's largest segment in fiscal 2025, bringing in $2.93B, or 47.8% of the $6.14B total across its four segments.
United States was Solventum's largest region in fiscal 2025, bringing in $4.67B, or 56.1% of the $8.33B total across its two regions.
Cost Of Product was Solventum's largest product and service line in fiscal 2025, bringing in $6.43B, or 76.5% of the $8.40B total across its two product and service lines.
United States grew faster than International in fiscal 2025, up 2.4% from $4.56B to $4.67B. International fell 1.0% to $3.66B.
Every figure comes from Solventum's annual financial filings, as reported. Each line keeps the name Solventum gives it, and years follow its fiscal calendar.
Solventum's revenue by segment goes back to fiscal 2022, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.